TUCSON, Ariz., Sept. 08, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. HTGM (HTG), a life science company whose mission is to advance precision medicine, today announced that company management will participate in H.C. Wainwright's 23rd Annual Global Investment Conference, being held September 13th – 15th, 2021.
Details for the presentation are below:
| Date: | 7:00 a.m. ET |
| Time: | Monday, September 13th, 2021 |
| Webcast: | https://journey.ct.events/view/36113800-95ac-4c91-b29a-d6ec60e0fddf |
Management will also be available for 1x1 meetings. If you would like to request a meeting, please email meetings@hcwco.com.
About HTG:
HTG is focused on NGS-based molecular profiling. The company's proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. Its mission is to empower precision medicine. To learn more, visit www.htgmolecular.com.
Contact:
Ashley Robinson
Phone: (617) 430-7577
Email: arr@lifesciadvisors.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
